Exploiting Folding and Degradation Machineries To Target Undruggable Proteins: What Can a Computational Approach Tell Us?
- 14 January 2021
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 16 (10) , 1593-1599
Abstract
Advances in genomics and proteomics have unveiled an ever‐growing number of key proteins and provided mechanistic insights into the genesis of pathologies. This wealth of data showed that changes in expression levels of specific proteins, mutations, and post‐translational modifications can result in (often subtle) perturbations of functional protein–protein interaction networks, which ultimately determine disease phenotypes. Although many such validated pathogenic proteins have emerged as ideal drug targets, there are also several that escape traditional pharmacological regulation; these proteins have thus been labeled “undruggable”. The challenges posed by undruggable targets call for new sorts of molecular intervention. One fascinating solution is to perturb a pathogenic protein's expression levels, rather than blocking its activities. In this Concept paper, we shall discuss chemical interventions aimed at recruiting undruggable proteins to the ubiquitin proteasome system, or aimed at disrupting protein‐protein interactions in the chaperone‐mediated cellular folding machinery: both kinds of intervention lead to a decrease in the amount of active pathogenic protein expressed. Specifically, we shall discuss the role of computational strategies in understanding the molecular determinants characterizing the function of synthetic molecules typically designed for either type of intervention. Finally, we shall provide our perspectives and views on the current limitations and possibilities to expand the scope of rational approaches to the design of chemical regulators of protein levels.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (20019)
This publication has 70 references indexed in Scilit:
- Structure-based drug design: aiming for a perfect fitEssays in Biochemistry, 2017
- Mutations at protein-protein interfaces: Small changes over big surfaces have large impacts on human healthProgress in Biophysics and Molecular Biology, 2017
- From Fuzzy to Function: The New Frontier of Protein–Protein InteractionsAccounts of Chemical Research, 2017
- Drugging Undruggable Molecular Cancer TargetsAnnual Review of Pharmacology and Toxicology, 2016
- Direct and Propagated Effects of Small Molecules on Protein–Protein Interaction NetworksFrontiers in Bioengineering and Biotechnology, 2015
- Insights into Disease-Associated Mutations in the Human Proteome through Protein Structural AnalysisStructure, 2015
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the RealityChemistry & Biology, 2014
- The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family MembersClinical Cancer Research, 2007
- Computational Alanine Scanning of Protein-Protein InterfacesScience's STKE, 2004
- A Combined Experimental and Computational Strategy to Define Protein Interaction Networks for Peptide Recognition ModulesScience, 2002